Testing of Nebulizers for Delivering Magnesium Sulfate to Pediatric Asthma Patients in the Emergency Department

被引:17
作者
Coates, Allan L. [1 ]
Leung, Kitty [1 ]
Vecellio, Laurent [3 ,4 ]
Schuh, Suzanne [2 ]
机构
[1] Univ Toronto, Res Inst, Dept Physiol & Expt Med, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Res Inst, Dept Populat Hlth, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[3] Univ Tours, Aerodrug, Tours, France
[4] Univ Tours, INSERM, Tours, France
关键词
aerosol delivery; asthma; pulmonary deposition; magnesium sulfate; nebulizer; DRUG OUTPUT; TOBRAMYCIN; DEPOSITION; CHILDREN; THERAPY; SIZE;
D O I
10.4187/respcare.00826
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: As the use of intravenous magnesium sulfate (MgSO4) for the treatment of refractory asthma is becoming more common, the incidence of MgSO4-related systemic hypotension is also rising. One option is to deliver MgSO4 via aerosol, but compared to most inhaled medications, which are active in the microgram dose range, the MgSO4 dose requirement is in the milligram range. This, along with inefficient aerosol delivery systems, may be the reason that some studies have found lack of efficacy with aerosol MgSO4. In preparation for a multicenter study of inhaled MgSO4 in asthmatic children 2-17 years old, we conducted an in vitro study to choose the best MgSO4 nebulizer system that would be effective over the entire age range. METHODS: We tested the Pari LC Star jet nebulizer, Omron MicroAir vibrating-mesh nebulizer, and the Aeroneb Go vibrating-mesh nebulizer with the Idehaler valve-less holding chamber. Aerosol delivery was via face mask. RESULTS: The Pari LC Star had an appropriate particle size distribution but a very slow aerosol output rate. The Omron MicroAir had an even slower output rate and a larger particle size distribution, which would be inappropriate for smaller children. In vitro lung deposition with the Aeroneb Go with Idehaler was 16.0 +/- 0.4 mg/min in older children and approximately a fifth of that in toddlers. CONCLUSIONS: The Aeroneb Go with Idehaler was chosen for the multicenter clinical study.
引用
收藏
页码:314 / 318
页数:5
相关论文
共 29 条
[1]   Comparison of nebulised magnesium sulphate and salbutamol combined with salbutamol alone in the treatment of acute bronchial asthma: a randomised study [J].
Aggarwal, P ;
Sharad, S ;
Handa, R ;
Dwiwedi, SN ;
Irshad, M .
EMERGENCY MEDICINE JOURNAL, 2006, 23 (05) :358-362
[2]  
Becker A, 2005, CAN MED ASSOC J, V173, pS3
[3]  
BLITZ M, 2005, COCHRANE DATABASE SY
[4]   A meta-analysis on intravenous magnesium sulphate for treating acute asthma [J].
Cheuk, DKL ;
Chau, TCH ;
Lee, SL .
ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 (01) :74-77
[5]   Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma [J].
Ciarallo, L ;
Brousseau, D ;
Reinert, S .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (10) :979-983
[6]   FACTORS INFLUENCING THE SIZE DISTRIBUTION OF AEROSOLS FROM JET NEBULIZERS [J].
CLAY, MM ;
PAVIA, D ;
NEWMAN, SP ;
CLARKE, SW .
THORAX, 1983, 38 (10) :755-759
[7]   Do sinusoidal models of respiration accurately reflect the respiratory events of patients breathing on nebulizers? [J].
Coates, AL ;
Macneish, CF ;
Allen, PD ;
Ho, SL ;
Lands, LC .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1999, 12 (04) :265-273
[8]   The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols [J].
Coates, AL ;
MacNeish, CF ;
Meisner, D ;
Kelemen, S ;
Thibert, R ;
MacDonald, J ;
Vadas, E .
CHEST, 1997, 111 (05) :1206-1212
[9]   Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition [J].
Coates, AL ;
Dinh, L ;
MacNeish, CF ;
Rollin, T ;
Gagnon, S ;
Ho, SL ;
Lands, LC .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2000, 13 (03) :169-178
[10]   How many infective viral particles are necessary for successful mass measles immunization by aerosol? [J].
Coates, AL ;
Tipples, G ;
Leung, K ;
Gray, M ;
Louca, E .
VACCINE, 2006, 24 (10) :1578-1585